跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 17,208 条关于
“Great Point Partners”
全部
17,208
临床试验
9,450
药物
38
机构
103
资讯
7,617
去年
Rezolute Secures $90 Million in Public Offering to Advance Rare Disease Therapies
5个月前
Sol-Gel Secures Patent Extension for Patidegib Until 2044, Raises $33.1M to Advance Gorlin Syndrome Trial
3个月前
Oak Hill Bio to Go Public via SPAC Merger, Secures $175 Million to Advance Rugonersen for Angelman Syndrome Through Phase 3
8个月前
Fresenius Kabi Partners with TQ Therapeutics to Develop Point-of-Care Cell Therapy Manufacturing System
去年
Great Southern Copper Reports High-Grade Cu-Ag Results from Mostaza Mine Drilling
去年
AI-Discovered ISM001-055 Shows Promise in Idiopathic Pulmonary Fibrosis Treatment
去年
New HER2 Test Could Expand Trastuzumab Deruxtecan Eligibility for Lung Cancer Patients
2年前
Nerandomilast Shows Promise in Phase 3 Trial for Idiopathic Pulmonary Fibrosis
2年前
FDA Panel Endorses Minimal Residual Disease (MRD) as Endpoint for Accelerated Approval in Multiple Myeloma
去年
Muscular Dystrophy Research Reaches Turning Point: Regeneration Emerges as Next Frontier
第 1 页,共 762 页
上一页
下一页